Atrial Fibrillation Market
Opportunities and Forecasts, 2014 – 2022
Pages: 138 Published: 2016
ATRIAL FIBRILLATION MARKET
Catheter ablation would propel the market growth with a very high rate, as these devices are used for the treatment of atrial fibrillation when medications are not effective. Catheter ablation procedure is very low risk and minimally-invasive in nature than other surgery (such as MAZE surgery).
Hemali Narkhede
ATRIAL FIBRILLATION MARKET OVERVIEW • Atrial Fibrillation Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $8,319 million by 2022, registering a CAGR of 13.0% during the period 2014 - 2022. • Non-surgical devices segment dominated the overall market in 2015. North America was the leading geographic segment in global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period. • Rise in prevalence rate of atrial fibrillation in geriatric population, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. Read more at : https://www.alliedmarketresearch.com/atrial-fibrillationmarket
TOP FACTORS IMPACTING GLOBAL ATRIAL FIBRILLATION MARKET
ATRIAL FIBRILLATION MARKET KEY BENEFITS • In-depth analysis of the market is conducted based on market estimations of the key segments for the period of 2014‐2022. • Comprehensive analysis of factors that drive and restrict the growth of the global atrial fibrillation market is provided in the report. • Exhaustive analysis by different segments aids tounderstand the different aspects of atrial fibrillation that are currently used along with the variants that would gain prominence in the future. • Competitive intelligence of leading manufacturers and distributors interprets the competitive scenario across various geographies. • Key market players and their strategies are analyzed thoroughly, to predict the competitive outlook of the global atrial fibrillation market share.
MEXICO: ATRIAL FIBRILLATION MARKET ($MILLION)
ATRIAL FIBRILLATION MARKET KEY FINDINGS • North America dominated the market of atrial fibrillation and is expected to maintain its lead throughout the forecast period, with a CAGR of 12.1% • Asia-Pacific is the fastest growing market and is estimated to grow at a CAGR of 14.7%
• Japan accounted for more than one-third share of the Asia-Pacific atrial fibrillation devices market in 2015 • The non-surgical equipment segment dominated in 2015, occupying largest revenue share and is anticipated to grow at a CAGR of 12.5% • Catheter ablation (sub segment for surgical equipment) accounted for largest market share in 2015 and is anticipated to grow at a CAGR of 13.8%
TOP INVESTMENT POCKETS IN GLOBAL ATRIAL FIBRILLATION MARKET
KEY PLAYERS IN INDUSTRY
• • • • • • • • • •
Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic plc, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, AtriCure Inc.
Download free Sample Report : https://www.alliedmarketresearch.com/request-toc/479
ATRIAL FIBRILLATION MARKET SEGMENTATION
CATHETER ABLATION MARKET, BY TYPE, 2015 Catheter ablation is the most commonly used surgical devices for the treatment of cardiac arrhythmias. It is recommended for the treatment of AF when anticoagulant drugs and other medications cannot be administered or tolerated by the patient. Therefore, this segment accounted for the major chunk of the overall market in 2015 and is expected to be the fastestgrowing market during the forecast period.
ATRIAL FIBRILLATION MARKET BY GEOGRAPHY North America, Europe, Asia-Pacific, LAMEA
Thank You!
For More Details Visit us at https://www.alliedmarketresearch.com/atrial-fibrillationmarket
Follow Us On